AIgnostikum GmbH

AIgnostikum, founded in Graz in 2019, is a medical technology company that develops software solutions for the diagnosis of breast and prostate cancer. The central software, RAIDAS (Radiology Artificial Intelligence Diagnostic Assistance System), uses AI algorithms to support radiologists in evaluating magnetic resonance images. RAIDAS generates BIRADS and PIRADS scores for cancer probability. MDR certification is planned by the end of 2024. The software offers radiologists valuable second opinions, marks lesions on MR images and integrates seamlessly into clinical practice. Target customers are diagnostic centers, radiologists and hospitals that benefit from precise and efficient cancer diagnosis.